Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason A Greenbaum

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Plos Pathogens|January 18, 2024
Late-rising CD4 T cells resolve mouse cytomegalovirus persistent replication in the salivary glandSimon Brunel, Gaelle Picarda, Ankan Gupta, et al.
Nature Communications|May 12, 2015
IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesisPetra Krause, Venetia Morris, Jason A Greenbaum, et al.
Frontiers in Immunology|March 29, 2021
TCRMatch: Predicting T-Cell Receptor Specificity Based on Sequence Similarity to Previously Characterized ReceptorsWilliam D Chronister, Austin Crinklaw, Swapnil Mahajan, et al.
Science Immunology|February 25, 2022
Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type-dependent effects of disease-risk variantsBenjamin J Schmiedel, Cristian Gonzalez-Colin, Vicente Fajardo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extractsCarla Oseroff, John Sidney, Randi Vita, et al.
JCI Insight|December 13, 2022
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cellsSpencer E Brightman, Martin S Naradikian, Rukman R Thota, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Linked CD4 <sup>+</sup> /CD8 <sup>+</sup> T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regressionJoseph S Dolina, Joey Lee, Spencer E Brightman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ)Cecilia S Lindestam Arlehamn, John Sidney, Ryan Henderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine designDaniela Weiskopf, Lauren E Yauch, Michael A Angelo, et al.
Cell|November 20, 2018
Impact of Genetic Polymorphisms on Human Immune Cell Gene ExpressionBenjamin J Schmiedel, Divya Singh, Ariel Madrigal, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Plos Pathogens|January 18, 2024
Late-rising CD4 T cells resolve mouse cytomegalovirus persistent replication in the salivary glandSimon Brunel, Gaelle Picarda, Ankan Gupta, et al.
Nature Communications|May 12, 2015
IL-10-producing intestinal macrophages prevent excessive antibacterial innate immunity by limiting IL-23 synthesisPetra Krause, Venetia Morris, Jason A Greenbaum, et al.
Frontiers in Immunology|March 29, 2021
TCRMatch: Predicting T-Cell Receptor Specificity Based on Sequence Similarity to Previously Characterized ReceptorsWilliam D Chronister, Austin Crinklaw, Swapnil Mahajan, et al.
Science Immunology|February 25, 2022
Single-cell eQTL analysis of activated T cell subsets reveals activation and cell type-dependent effects of disease-risk variantsBenjamin J Schmiedel, Cristian Gonzalez-Colin, Vicente Fajardo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 13, 2012
T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extractsCarla Oseroff, John Sidney, Randi Vita, et al.
JCI Insight|December 13, 2022
Tumor cells fail to present MHC-II-restricted epitopes derived from oncogenes to CD4+ T cellsSpencer E Brightman, Martin S Naradikian, Rukman R Thota, et al.
Biorxiv : the Preprint Server for Biology|May 19, 2023
Linked CD4 <sup>+</sup> /CD8 <sup>+</sup> T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regressionJoseph S Dolina, Joey Lee, Spencer E Brightman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2012
Dissecting mechanisms of immunodominance to the common tuberculosis antigens ESAT-6, CFP10, Rv2031c (hspX), Rv2654c (TB7.7), and Rv1038c (EsxJ)Cecilia S Lindestam Arlehamn, John Sidney, Ryan Henderson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2011
Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine designDaniela Weiskopf, Lauren E Yauch, Michael A Angelo, et al.
Cell|November 20, 2018
Impact of Genetic Polymorphisms on Human Immune Cell Gene ExpressionBenjamin J Schmiedel, Divya Singh, Ariel Madrigal, et al.
Pageof 7